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Summary
Objective: Both, matrix-assisted chondrocyte transplantation (MACT) and osteochondral autograft transplantation (OCT), are applied for treat-
ment of articular cartilage defects. While previous clinical studies have compared the respective outcome, there is no such information inves-
tigating the ultrastructural composition using T2 mapping comparing cartilage T2 values of the repair tissue (RT).
Methods: Eighteen patients that underwent MACT or OCT for treatment of cartilage defects at the knee joint (nine MACT, nine OCT) were
matched for gender (one female, eight male pairs), age (33.8), body mass index (BMI) (28.3), defect localization, and postoperative interval
(41.6 months). T2 assessment was accomplished by T2 maps, while the clinical evaluation included the Lysholm and Cincinnati knee scores,
a visual analogue scale (VAS) for pain, the Tegner activity scale, and the Short Form-36.
Results: Global T2 values of healthy femoral cartilage (HC) were similar among groups, while T2 values of the RT following MACT (46.8 ms,
SD 8.6) were signiﬁcantly lower when compared to RT T2 values after OCT (55.5 ms, SD 6.7) (P¼ 0.048). MACT values were also signiﬁ-
cantly lower in comparison to HC (52.5 ms, SD 7.9) within MACT patients (P¼ 0.046), while OCT values were signiﬁcantly higher compared to
HC (49.9 ms, SD 5.1) within OCT patients (P¼ 0.041). The clinical outcome following MACT was consistently superior to that after OCT while
only the Lysholm score reached the level of signiﬁcance (MACT 77.0, OCT 66.8; P¼ 0.04).
Conclusion: These ﬁndings indicate that MACT and OCT result in a different ultrastructural outcome, which is only partially represented by the
clinical picture.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Adult articular cartilage, once damaged, fails to restore its
native structure1. Autologous osteochondral autograft trans-
plantation (OCT)2 and autologous chondrocyte
transplantation (ACT)3 including further generations such
as matrix-assisted chondrocyte transplantation (MACT)
are privileged surgical methods to treat medium and large
diameter articular defects4. The evaluation of graft matura-
tion and long-term fate is important information for quality
control and future treatment principles, in particular, since
both treatment methods imply disadvantages following their
application, which may interfere with the transplant integra-
tion or maturation to potentially deteriorate the structural
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1576MACT monolayer expanded and thus, dedifferentiated
chondrocytes, are implanted potentially unable to generate
hyaline cartilage5. In most cases, hyaline-like cartilage and
more often ﬁbrocartilage evolves within the defect region6,7,
while it is also known that in certain cases the repair tissue
(RT) does not completely integrate or extend through the
entire cartilage thickness, grafts delaminate or procedures
simply fail8,9. Following OCT, chondrocytes aligning the sur-
face are known to undergo signiﬁcant degeneration after in-
jurious compression during surgery10, chondral integration
fails to appear, while transplanted cartilage has been shown
to degenerate already at 3 months after implantation11e13.
Therefore, cartilage repair procedure monitoring constitutes
an increasingly important practice to assure the outcome,
and possibly prevent further cartilage breakdown leading
to an eventual progression of osteoarthritis (OA). This be-
comes particularly true since it has been shown that
in vivo graft characteristics do not necessarily correlate to
the clinical picture14. Potential degeneration or even trans-
plant failure may be missed during clinical or conventional
radiographic evaluation. Even though arthroscopic biopsies
have been performed in the past15,16 to accurately classify
the RT in regard of its histological and foremost
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magnetic resonance imaging (MRI) have demonstrated the
ability of this technique to provide expedient information
about the RT17. In comparison to the histological examina-
tion, the tissue surrounding and opposing the graft material
as well as superﬁcial and deeper parts of its underlying
bone can be entirely assessed without surgery or radiation
by the use of MR-examinations, while biopsies give only se-
lected information and furthermore may alter the future in-
tegrity of the transplanted tissue6. Besides the evaluation
of gross cartilage morphology, novel MR sequences, such
as T2 mapping, allow for determination of the major ultra-
structural components of cartilage: water, collagens and
glycosaminoglycans18. Herewith, quantitative measures of
T2 relaxation may be useful in the characterization and
long-term tracking of MACT or OCT to gain information
about the in vivo tissue performance mainly in terms of
gradual maturation and native differentiation, but also the
initial stages of OA, including proteoglycan loss, increased
water content, and disorganization of the collagen net-
work14,19,20. A valid MR snapshot of the RT would allow
for evaluation of the implanted graft material in terms of in-
tegration, differentiation and viability. Therefore, it was the
goal of this study to assess T2 relaxation times of the repair,
adjacent as well as opposite tissue following MACT or OCT
in a matched patient population to compare the in vivo graft
architectural morphology in combination with the clinical
outcome.
MethodsSUBJECTSFig. 1. Direct intraoperative visualisation of a MACT transplant at
the medial femoral condyle (A) with backup stitches and two OCT
autografts (B) at the patella undersurface.A total of 18 patients following either MACT (eight male, one female) or
OCT (eight male, one female) were matched for gender (one female pair,
eight male pairs), age (MACT 32.7 7.2 years; OCT 33.9 7.5 years),
body mass index (BMI) (MACT 26.9 4.7; OCT 26.9 4.6), cartilage defect
localization (medial femoral condyle: six MACT, six OCT; patella: two
MACT, two OCT; lateral femoral condyle: one MACT, one OCT) and post-
operative interval (MACT 42.0 17.4 months, range 25e77 months; OCT
41.3 16.5 months, range 23e75 months). All patients were treated for
symptomatic cartilage lesions according to the International Cartilage Repair
Society (ICRS) classiﬁcation 3e421. MACT was performed in patients with
ICRS 3e4a lesions and a defect size above 3 cm2, while OCT was per-
formed in patients with ICRS 4a, 4b lesions and a defect size of less than
3 cm2 (and larger than 1 cm2; one patient was included with a 0.9 cm2 le-
sion). Among MACT patients, there were four patients with ICRS 3 lesions
(three medial femoral condyle, one patella) and ﬁve patients with ICRS 4a
lesions (three medial femoral condyle, one patella and one lateral femoral
condyle). Of the MACT patients, seven reported about previous traumatic
events, while two reported on subtle symptom improvement. Of the OCT pa-
tients, six had ICRS 4a lesions (ﬁve medial femoral condyle, one patella),
while three had ICRS 4b lesions (one medial femoral condyle, one lateral
femoral condyle, one patella). The mean defect size within OCT patients
was 2.3 cm2 (0.9e2.6 cm2), while it was 6.3 cm2 (3e12 cm2) in the MACT
group. Three OCT patients had a previous osteochondrosis dissecans
(two at the medial femoral condyle, one at the lateral femoral condyle),
one suffered from a previous patellar ﬂake fracture, two patients reported
about a traumatic event and three had subtle symptom improvement. Exclu-
sion criteria for MACT or OCT were obesity (BMI> 35), OA (>grade 1 ac-
cording to the Kellgren and Lawrence classiﬁcation22), rheumatoid
arthritis, absence or extensive meniscal loss, ligamentous instability, active
local or systemic infections, inﬂammatory arthropathy, varus or valgus defor-
mity of more than 2 and limited range of motion with active knee ﬂexion be-
low 120 or an extension deﬁciency exceeding 15. All patients that
underwent MACT were arthroscopically assessed and the cartilage biopsy
for chondrocyte isolation and expansion was harvested within this ﬁrst pro-
cedure. The second stage transplantation (MACI; Verigen, Leverkusen, Ger-
many) was performed by use of an open approach according to the
technique described by Cherubino23. The cartilage defects in all patients
treated by OCT (OATS, Arthrex, Naples, FL, USA) were assessed
arthroscopically and subsequently treated by an open approach (Fig. 1).
The diameter of the transplanted cylinders (OCT) was 10 mm in every pa-
tient with a mean number of 1.5 1.0 transplanted cylinders. The study
was approved by the local Institutional Review Board, and all patients
signed an informed consent prior to evaluation.IMAGE ACQUISITIONMR imaging was performed with an 1.5 T MR scanner (Siemens Avanto;
Siemens Medical Solutions, Erlangen, Germany), equipped with 40 mT/m
gradients, using a dedicated 8-channel knee coil (Medical Advances, Milwau-
kee, WI, USA). All patients were positioned in a consistent fashion, with a fully
outstretched leg, the joint space of the knee centered in the coil. They had res-
ted in the supine position at least half an hour before imaging. A standard knee
protocol was acquired in all patients; it consists of a fat-saturated (fs) interme-
diate-weighted (IM-w) turbo spin echo (tse) sequence in the sagittal and cor-
onal plane as well as a sagittal T1 weighted tse sequence with a driven
equilibrium (DRIVE) pulse. In case of cartilage transplants at the patella, axial
IM-w images were acquired instead of coronal ones. All sequences were ac-
quired with a ﬁeld of view (FOV) of 16 cm, section thickness of 3 mm, an ac-
quisition matrix of 384 384 and a bandwidth of 64 Hz/pixel. The IM-w
sequences had an echo time (TE) of 44 ms, a repetition time (TR) of
4250 ms and an echo train length (ETL) of 9, while the T1-w sequence had
a TE of 15, a TR of 647 and an ETL of 3. In average, 26 sections were ob-
tained per sequence in 4:30 min. Based on these sequences, the site of car-
tilage repair was identiﬁed. An additional T2 relaxation time acquisition was
performed for this region, using the plane that best visualized the site of car-
tilage repair. A multi-echo spin-echo acquisition was acquired with a TR of
1500 ms and 10 TEs (9, 18, 27, 36, 45, 54, 63, 72, 81, 90 ms), a FOV of
16 cm, an acquisition matrix of 256 256 at a bandwidth of 240 Hz/pixel re-
sulting in a time of acquisition of 6:24 min (Fig. 2). For T2 relaxation time ac-
quisition all transplants at the femoral condyles were imaged in sagittal
planes, while all patellar transplants were imaged in the axial plane in addition.IMAGE ANALYSIST2 relaxation time maps were calculated pixelwise from nine spin-echo
images (echoes 2e10 from the stimulated echo) using a monoexponential
Fig. 2. T1-w (A, B) and IM-w (C, D) MR images as well as corresponding color-coded, superimposed T2 maps (E, F) of patients after MACT
(A, C, E) and OCT (B, D, F) procedures, respectively.
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Creaso, Gilching, Germany) for exclusion of the initial spin-echo artefacts
in the T2 calculation24. By combining the information of all obtained se-
quences and the surgical documentation, the area of cartilage RT was deter-
mined. Regions of interest (ROIs) were drawn manually by one
musculoskeletal radiologist and one orthopedic surgeon in consensus.
ROIs were selected in weight bearing areas at an orientation perpendicularto the magnetic ﬁeld in case of cartilage repair at the femoral condyles or par-
allel to the magnetic ﬁeld in case of retropatellar cartilage repair. ROIs cov-
ering the full thickness of the cartilage were positioned in the cartilage RT (1),
immediate edges of the cartilage RT (2), adjacent regions of the cartilage RT
(3), the opposing cartilage of the cartilage RT (4), healthy femoral cartilage
(HC) (5) and healthy tibial cartilage (Fig. 3). Margins of the cartilage RT
were identiﬁed. The region from the respective immediate margin 1 mm
Fig. 3. Color-coded T2 map with analysed ROIs: 1 e cartilage
transplant; 2 e immediate edges; 3 e adjacent regions; 4 e op-
posed cartilage; 5 e healthy femoral cartilage. The ROI of healthy
tibial cartilage is not visible in this section. The bar on the right gives
the color speciﬁc T2 values in ms.
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gion in between both immediate margins as the cartilage RT and the carti-
lage ﬂanking the immediate margins 4 mm anterior and posterior as the
adjacent regions. The regions of healthy femoral and tibial cartilage were
chosen in equal size as the measured cartilage RT. Among the patellar le-
sions, which were measured on axial images, no tibial cartilage was mea-
sured. No ROI has been placed in a cartilage region angulated between
40 and 70 to the magnetic ﬁeld25. Healthy femoral cartilage was measured
contralateral if no degeneration was present or otherwise in the posterior re-
gion of the same condylus (parallel to the magnetic ﬁeld). The T2 index and
in addition the MOCART score were calculated as described before26,27. The
individual T2 index, which is a non-dimensional coefﬁcient, is calculated in
expressing global mean T2 of the RT relative to global mean T2 of healthy
cartilage. The MOCART score includes nine different variables to describe
the morphology and signal intensity of the RT compared to the adjacent na-
tive cartilage: degree of defect repair and ﬁlling, integration to border zone,
surface, structure and signal intensity of the RT, subchondral lamina and
bone, adhesions and effusion. An absolute number between 0 and 100 rep-
resents the percentage of the total possible achievable score. To include re-
producibility measurements, additional reproducibility measurements (three
OCT, three MACT) have been measured three times each. Reproducibility
error was calculated as root-mean-square-average of the single coefﬁcients
of variation.CLINICAL EVALUATIONThe modiﬁed Lysholm28 score, the modiﬁed Cincinnati29 knee rating sys-
tem, a visual analogue scale (VAS) for pain (0 representing ‘‘no pain’’ and 10
representing ‘‘maximal imaginable pain’’), the Tegner30 activity scale and the
Short Form-36 (SF-36) (compared to a healthy german collective set as the
50th percentile)31,32 were used to assess the clinical outcome at the time of
the MR-examination.STATISTICAL ANALYSISStatistical analysis was performed using the software package SPSS
(Version 17, SPSS Inc, Chicago, Ill, USA). To account for potential underes-
timation of variance due to matching, differences between MACT and OCT
patients, in regard to quantitative data, were statistically assessed by the
use of covariance analysis including matching variables age and BMI as ad-
justment covariates. Residual plots were investigated for assessment of
model ﬁt and the 95% conﬁdence limits for adjusted mean group differences
were reported. For comparison of speciﬁc T2 values compared to HC among
MACT or OCT patients only, respectively, the Wilcoxon text was used. Cor-
relation analyses were performed using Spearman’s correlation coefﬁcient
(r). Descriptive results were demonstrated as the mean  standard deviation
(SD). When comparing MACT with OCT patients (Tables I and II), the SDand 95 % conﬁdence interval (CI) of the mean difference with corresponding
P value adjusted for matching variables age and BMI was given. All statisti-
cal tests were conducted two-sided and a P value <0.05 was considered to
indicate statistical signiﬁcance.Results
Mean global T2 values of the RT ranged from 32 to 80 ms
(mean 51.6 ms, SD 10.7), while mean global T2 values of
healthy articular cartilage ranged from 43 to 61 ms (mean
50.14 ms, SD 8.3). Mean T2 values of HC were not signiﬁ-
cantly different comparing all MACT patients (52.5 ms, SD
7.9) with all OCT patients (49.9 ms, SD 5.1) (Table I). T2
values following MACT ranged from 35 to 57 ms (mean
46.8 ms, SD 8.6) and were signiﬁcantly lower (P¼ 0.048)
when compared to T2 values after OCT that ranged from
48 to 68 ms (mean 55.5 ms, SD 6.7). Among MACT pa-
tients only, values of the RT (P¼ 0.046), of opposed carti-
lage (P¼ 0.024) and tibial cartilage (P¼ 0.032) were
signiﬁcantly different (lower) in comparison to HC values
of MACT patients only. Among OCT patients only, values
of the RT (P¼ 0.041) and values of the adjacent regions
(P¼ 0.048) were signiﬁcantly different (higher) compared
to HC values of OCT patients only. Furthermore, there
was no signiﬁcant difference for the additional ROIs sur-
rounding or adjacent to the RT when comparing MACT
and OCT patients. The T2 index was signiﬁcantly different
(P< 0.001) between MACT and OCT patients, while there
was no signiﬁcant difference for the MOCART score. There
was no signiﬁcant difference between groups in terms of
presence or absence of subchondral bone marrow edema,
granulation tissue, cysts or joint effusion. Measurement of
reproducibility was as follows: RT among OCT patients
5.6%, anterior edge of RT 7.8%, posterior edge of RT
6.2%, opposed cartilage of RT 3.8%, adjacent regions
9.7%, femoral HC among OCT patients 4.1%, healthy tibial
cartilage among OCT patients 6.6%. RT among MACT pa-
tients 5.9%, anterior edge of RT 4.8%, posterior edge of RT
6.1%, opposed cartilage of RT 4.7%, adjacent regions
5.9%, femoral HC among MACT patients 5.7%, healthy tib-
ial cartilage among MACT patients 1.7%.
The overall clinical outcome was constantly higher within
the MACT patients in comparison to the OCT patients, while
statistical signiﬁcance (P¼ 0.04) was only found for the Ly-
sholm score (Table II). However, no signiﬁcant correlation
between the clinical and the ultrastructural outcome was
proven. Only among MACT patients, the Lysholm score
was correlated to the RT T2 value (rs¼ 0.734, P¼ 0.038).
Age, gender, BMI, defect location, or defect size did not cor-
relate with the respective T2 values or the clinical outcome.Discussion
For treatment of articular cartilage defects, an effective
and lasting repair is a necessity to prevent an early onset
of osteoarthritis1,33. Lack of differentiated local functional
and/or structural chondral composition is jeopardizing the
RT long-term durability, therefore deﬁning a predisposition
for local and potentially generalized disease progres-
sion34,35. In this regard, following OCT, signs of degenera-
tion can appear either in clinical symptoms, during
arthroscopy6, or on gross MRI36. The same holds true for
chondrocyte transplantation, which has been shown to re-
sult in a satisfying clinical outcome while arthroscopy and/
or histology revealed mostly hyaline-like or ﬁbrous cartilage
within the graft tissue37,38. Thus, monitoring the structural
Table I
T2 values of the RT, HC, edges, adjacent and opposing regions of the RT
T2 RT T2 HC Anterior edge Posterior edge Adjacent regions Opposed cartilage Tibial cartilage
MACT (n¼ 9) 46.8 52.5 47.9 50.9 48.9 44.4 46.4
SD 8.6 SD 7.9 SD 10.3 SD 11.0 SD 6.7 SD 8.2 SD 8.6
OCT (n¼ 9) 55.5 49.9 45.1 48.9 53.1 48.3 48.7
SD 6.7 SD 5.1 SD 5.5 SD 7.6 SD 6.2 SD 6.8 SD 9.1
95% CI 0.1 to 17.2 18.1 to 3.0 11.9 to 5.6 13.1 to 8.6 3.3 to 11.2 4.2 to 12.2 6.4 to 12.0
P value 0.048 0.146 0.453 0.661 0.262 0.309 0.526
T2 values (ms) and SD of the RT of HC, of the anterior edge of the RT, the posterior edge of the RT (circumferential within patellar defects),
directly adjacent regions to the RT, opposed cartilage of the RT and healthy tibial cartilage. 95 % CI of mean difference between MACT and
OCT patients with corresponding P value adjusted for matching variables age and BMI.
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in vivo performance, in particular as structural appearance
not necessarily correlates with the clinical condition14. Since
biopsies give only limited insight into the RT, no clinical
study represents a complete histologic analysis of the re-
sulting RT. In replacement, non-invasive MRI has become
the method of choice to characterize gross morphology
and within recent developments also the ultrastructural
components of any cartilage RT39e46. This becomes partic-
ularly important in the light of the constant emergence of
novel procedures for cartilage repair47 to assess general
feasibility and long-term fate48e51 or to compare potentially
established methods without invading the RT52. While there
have been a variety of studies comparing mainly the clinical
outcome resultant of different cartilage repair procedures,
only a few have comprised quantitative imaging for struc-
tural analysis of the RT. Comparable to this study, Bentley6
and Horas53 have previously compared the clinical, arthro-
scopic and partially radiographic/histologic outcome follow-
ing autologous chondrocyte and osteochondral autograft
transplantation, respectively. Horas reported a similar clini-
cal outcome, satisfying arthroscopic appearance after OCT
and an inferior histologic appearance following ACT. The bi-
opsies (n¼ 5) following OCT were representative of cleft
formations surrounding the cylinders with normal appearing
transplantated cartilage, while the RT following ACT (n¼ 8)
consisted mainly of ﬁbrocartilage. Bentley, in contrast, dem-
onstrated inferior clinical results together with an inferior ar-
throscopic (n¼ 23) appearance following OCT (no biopsies
were taken). The clinical information by Bentley parallels
our data. Despite the fact that the mean defect size was dif-
ferent between groups, the overall clinical outcome follow-
ing MACT was superior to that after OCT, while only the
Lysholm score reached the level of signiﬁcance. The differ-
ence between the two patient cohorts was more evidentTable I
Clinical outcome followin
Lysholm Cincinnati VAS
MACT (n¼ 9) 77.0 74.3 1.9
SD 9.9 SD 16.2 SD 0
OCT (n¼ 9) 66.8 68.3 2.5
SD 9.9 SD 18.3 SD 2
95 % CI 22.0 to 0.59 21.5 to 3.6 1.3 to
P value 0.04 0.12 0.4
Absolute values and SD of the Lysholm knee score, the Cincinnati sco
physical component scale (PCS) and mental component scale (MCS). 9
corresponding P value adjusted for matching variables age and BMI.when analysing the T2 times, where signiﬁcant differences
within the RT following MACT (46.8 ms) were identiﬁed
when compared to those following OCT (55.5 ms). The
global mean T2 relaxation time of healthy articular cartilage
(51.6 ms) within all patients from our study is comparable to
previously reported values24,52,54. Interestingly, T2 values
of healthy appearing cartilage among the OCT patients
were reduced when comparing to data from the literature.
In contrast to that, the cylinder itself had signiﬁcantly ele-
vated T2 times that are possibly related to a previously re-
ported increased water content55, which has been
described as an early sign of degenerated cartilage and
consequently a possible early sign of OA. White and
co-workers analysed T2 values following osteochondral au-
tologous plug transplantation and microfracturing (Mfx) pro-
cedures dividing the RT into deep, middle and superﬁcial
zones56. Only among the transplanted cylinders a signiﬁcant
difference was detected between the different zones repre-
sentative of more hyaline-like cartilage following OCT. How-
ever, T2 values within the OCT transplants were elevated
when compared to the surrounding HC, a ﬁnding that was
pronounced within the OCT harvest regions. This informa-
tion corresponds well to data from our analysis, where
OCT plugs also represented elevated T2 values when com-
pared to healthy control cartilage52. White furthermore de-
scribed an abnormal T2 time in the superﬁcial layer of the
RT following Mfx, which could be interpreted as an unorga-
nized ﬁbrocartilage tissue possibly resultant to detrimental
joint pressure at the immature graft surface. Comparable re-
sults were as well reported by Welsch and colleagues when
comparing T2 maps following MACT and Mfx RT52. While
Mfx resulted in signiﬁcantly reduced global T2 values, the
radiologic quantiﬁcation following MACT resulted in HC
matchable T2 signals, contradicting our data. Reasons for
that may either be found due to different cell-matrixI
g MACT and OCT
Tegner SF-36 PCS SF-36 MCS
5.4 52.4 52.5
.8 SD 1.9 SD 2.7 SD 3.4
5.0 48.8 46.6
.2 SD 2.1 SD 8.2 SD 8.8
2.5 2.6 to 1.8 12.7 to 6.0 16.6 to 4.6
9 0.69 0.45 0.24
ring system, the VAS for pain, the Tegner activity index, the SF-36
5 % CI of mean difference between MACT and OCT patients with
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fold (Hyalograft C; Fidia Advanced Biopolymers, Abano
Terme, Italy) was used in the study by Welsch, or a shorter
postoperative examination interval (27.4 months, compared
to 41.6 months in our study). Natural maturation processes,
which elapse within the RT, may last for more than 3 years
and a potential tissue endpoint may not have been de-
scribed in the study by Welsch, while later T2 values may
approximate these of HC or shift into ﬁbrous tissue at later
postoperative stages. Such ﬁbrous tissue, even though
a third generation transplant has been applied, claiming to
use re-differentiated articular chondrocytes, may have re-
sulted in the depressed relaxation times within the MACT
RT from our collective when compared to internal control
and to global RT T2 values (56 ms52 and 50 ms within the
RT deep layer/57 ms within the RT superﬁcial layer40 fol-
lowing MACT) within previous studies. Information on ﬁ-
brous or hyaline-like cartilage following chondrocyte cell
transplantation is not new and comparable to previously de-
scribed histology that examined tissue extracted after chon-
drocyte transplantation7,53. Contrariwise, tibial cartilage
following MACT was signiﬁcantly reduced in T2 relaxation
when comparing to HC within the MACT cohort, although
it is known that T2 values of tibial cartilage are commonly
lower than femoral ones. This constellation, however, was
even more pronounced within the tibial cartilage directly op-
posing the graft. Protracted maturation processes following
cell transplantation may alter the opposing joint surface.
Contrary to that, there was no difference in tibial and femo-
ral cartilage among the OCT patients. However, signiﬁ-
cantly different T2 times were recorded within the
immediate adjacent regions surrounding the cylinders.
This is according to previous information, where it was
shown that OCT plugs do not integrate at the chondral mar-
gin, where instead degeneration can be found in the sur-
roundings of the transplant13,57.
Clear limitations of the study include a rather small num-
ber of patients. However, matching patients for age, gender,
BMI, cartilage defect localization and postoperative interval
severely reduced the number of available patients. Syn-
chronously, the matched patient population represents
a clear strength of this study in minimizing patient bias. De-
fect sizes among subjects from the different groups were
not similar, which is related to the fact that lesions up to
3 cm2 are commonly approached using OCT at our depart-
ment, while defects with a larger diameter are usually
treated using ACT. Comparison of different defect sizes
has been previously reported, but will remain an issue of
debate since the comparison of naturally different repair
procedures immediately involves size discrepancies. Also,
comparing patellar defect localizations may have affected
the respective outcome related to the fact that patello-fem-
oral cartilage defects are frequently associated with other
underlying disorders. Furthermore, there is a lack of analy-
sis concerning T2 variation along the cartilage-depth, such
as superﬁcial and deep zones of the cartilage since it was
challenging to vertically divert the analysed cartilage in
a fully reproducibly manner representing the true anatomy.
The effect of orientation of cartilage zone relative to the
static magnetic ﬁeld on T2 assessment, as previously
shown by Mosher and colleagues25, has not been de-
scribed as well. Strengths of this study are to be found in
the postoperative interval (at least 3 years follow-up) which
can be regarded as an endpoint after cartilage repair, espe-
cially when graft maturation is concerned following chondro-
cyte transplantation. Additionally, regions adjacent to the
transplants have previously not been analysed.In conclusion, the data show that MACT and OCT proce-
dures result in different T2 values and Lysholm scores in
a matched patient population. Information that was gath-
ered from the T2 maps is comparable to previous histologic
information, therefore describing T2 relaxation as an appli-
cable tool for cartilage repair graft monitoring. More work
has to be done to more clearly interpret elevated and de-
pressed T2 values to utilize the information in the future
and to potentially justify a surgical intervention for the ben-
eﬁt of the patient.Conﬂict of interest
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